Mats Pettersson, B.Sc. (Economics and Business Administration), was born on 7 November 1945 and is a Swedish citizen. He was elected to Lundbeck's Board of Directors in 2003 and elected as Chairman in 2011. He also chairs Lundbeck's Remuneration Committee and is a member of the Audit Committee.
Mats Pettersson has many years' experience from international research-based pharmaceutical companies. He has held various positions in Business Development and has served as CFO, CEO and as member of various management committees.
Mats Pettersson's special qualifications for serving on Lundbeck's Board of Directors include his experience with senior management, research and development processes, and Business Development combined with substantial international experience.
He is board chairman of Moberg Derma AB, and board member of Ablynx NV, to-BBB NV, Aquapharm Biodiscovery Ltd and Photocure AS.
Hide details
Christian Dyvig, LL.M, MBA, was born on 11 October 1964 and is a Danish citizen. He was elected to Lundbeck’s Board of Directors at the 2011 annual general meeting. He is also a member of Lundbeck’s Scientific Committee.
Christian Dyvig brings with him years of experience from the financial sector, focusing especially on the transfer of undertakings, and substantial ownership experience from a range of enterprises. He served as Managing Director at Morgan Stanley in 2000-2003, partner in Nordic Capital 2003-2009, and director/chairman of the board in a number of businesses in which he also has personal ownership (among them Falck A/S, Kompan A/S and FIH Erhvervsbank A/S) in 2009-2011. As of 1 June 2011, he has been Managing Director at the Lundbeck Foundation.
As far as his work on the Lundbeck’s board of directors is concerned, Christian Dyvig's special competencies lie in his financial knowledge, his experience within the transfer of undertakings area, and his experience as an active owner representative.
Christian Dyvig is a director of FIH Erhvervsbank A/S.
Hide details
Thorleif Krarup, B.Sc. (Economics) and Bachelor of Commerce (Business Finance and Management Accounting), was born on 28 August 1952 and is a Danish citizen. He was elected to Lundbeck's Board of Directors in 2004 and elected as Deputy Chairman in 2005. He is also a member of Lundbeck's Audit Committee.
Thorleif Krarup has many years' experience from the financial sector as Group Chief Executive of Nykredit (1987 to 1992) and Group CEO of Unibank (1992 to 2002) and Nordea (2000 to 2002). Since 2002, he has been board chairman of several listed/international companies and senior adviser in international institutions.
Thorleif Krarup's special qualifications for serving on Lundbeck's Board of Directors include management experience from international organisations, knowledge of the Lundbeck Group's business and practice, and qualifications within global management control, particularly accounting, financing, and the capital market.
Thorleif Krarup is board chairman of Alk-Abello A/S, Exiqon A/S and Sport One Danmark A/S, deputy board chairman of LFI A/S and Falck A/S, and board member of the Lundbeck Foundation.
Hide details
Melanie G. Lee, Ph.D., CBE, FMedSci. D.Sc (Hons), born 29 July 1958, English citizen, elected as a member of the 2012 Annual General Meeting.
Melanie G. Lee has a broad academic background and many years of experience from the pharmaceutical industry. She has held several executive positions, most recently as Research and Development Director and member of the management board of Celltech plc. and as Executive Vice President for R&D of UCB where she was also a member of the management board. In 2010 she became Chief Executive Officer of Syntaxin and in 2011 she became board member of BTG plc.
Melanie G. Lee's special qualifications for serving on Lundbeck's Board of Directors include her top management experience and her knowledge of research and development in the pharmaceutical industry.
Hide details
Jes Østergaard, M.Sc. (Chemical Engineering), was born on 5 March 1948 and is a Danish citizen. He was elected to Lundbeck's Board of Directors in 2003. He also chairs Lundbeck's Scientific Committee and is a member of the Remuneration Committee.
Until 1 February 2008, Jes Østergaard was CEO of ilochip A/S. He was previously CEO of Dako A/S and Managing Director of Medicon Valley Academy. He has also been Corporate Vice President of Novo Nordisk A/S.
Jes Østergaard's special qualifications for serving on Lundbeck's Board of Directors include management experience from international research-based companies, knowledge of the Lundbeck Group's business and practice, human resource experience, and experience with group development, including acquisition and sale of businesses.
Jes Østergaard is board member of ALK-Abello A/S, the Lundbeck Foundation, LFI A/S, Scion-DTU A/S, and HEED Diagnostics.
Hide details
Håkan Björklund, Ph.D (neuroscience), was born 14 April 1956 and is a Swedish citizen. He was elected to Lundbeck’s Board of Directors at the 2011 annual general meeting. He is also a member of Lundbeck’s Remuneration Committee and Scientific Committee.
Håkan Björklund is working as Healthcare Operating Executive at Avista Capital Partners. He has years of international experience from the pharmaceutical industry. Having been in charge of the research activities of Astra AB for a number of years, he was later responsible for the company's sales and marketing in the Nordic region, certain countries in Europe and South Africa. From 1999-2011 he was CEO of Nycomed GmbH.
Håkan Björklund's special qualifications in relation to the board work in Lundbeck are his knowledge of pharmaceutical research and development and his knowledge of the industry.
Håkan Björklund serves on the boards of Atos Medical AB and Coloplast A/S.
Hide details
Mona Elisabeth Elster has been employed with Lundbeck since 1994. She works in Discovery Chemistry & DMPK and was appointed Senior Lab Technician in 2009.
Mona Elisabeth Elster finished her Lab Technician education in 1984 and received a Marketing Diploma in 1989. She has previously worked with the Carlsberg Research Center, the Royal Veterinary and Agricultural University in Denmark, the Faculty of Pharmaceutical Sciences under the University of Copenhagen, and Danisco.
Since 1995, Mona Elisabeth Elster has been a member of the board of Lundbeck's salaried employees' association, where she was appointed chairman in 2002.
Hide details
Jørn Mayntzhusen has been with Lundbeck since 2002 currently being Senior Manager for Supply Optimisation and Launches of new products. Previously Jørn Mayntzhusen has been responsible for Production Planning and Costing, as well as head of Customer Supply.
Originally educated as a banker in 1988 he has obtained a BSc in Logistics (HD(L)) at Copenhagen Business School in 1995 and a Master of Business Administration (MBA) from Edinburgh Business School in 2002.
Jørn Mayntzhusen started working with Handelsbanken 1986-1990 followed by 2 years at Thule Air Base with Greenland Contractors 1990-1992. In 1992 he started studying for his BSc and was employed as Logistic Assistant with Braun Nordic 1993-1997. For the next 2 years Jørn Mayntzhusen worked as Business Management Advisor with Mellemfolkeligt Samvirke in Zimbabwe. Prior to working for Lundbeck Jørn was Nordic Logistic Manager with Moulinex Krups 1999-2002.
Hide details
Kim Rosenville Christensen is a Synthesis Operator and has been with Lundbeck since 1993. Prior to joining Lundbeck Kim Rosenville Christensen served in the Danish Armed Forces from 1976 to 1993. He has obtained a degree as a plant operator. Kim Rosenville Christensen has acted as shop steward for the employees at the F1 plant in Lumsås since 1999 and senior shop steward covering the Danish Trades Union Congress area since 2004.
Hide details
